Most Recent
Pelvic mesh maker Astora may make admissions in class action in light of J&J case
Pelvic mesh device maker Astora Women's Health is weighing whether to make admissions in a class action over allegedly defective products in light of a similar, high profile class action brought against Johnson & Johnson unit Ethicon over the devices.
Court to hear another COVID-19 business interruption test case
A group representing insurers has filed another test case over pandemic coverage in business interruption policies, following a landmark loss in a test case concerning an infectious disease exclusion that could cost insurers $10 billion.
Baker McKenzie repped client for two and half years that did not exist, court told
For two and a half years, law firm Baker McKenzie represented a client in class action litigation over allegedly defective pelvic mesh products that did not exist, a court has heard.
$27M settlement rejected in pelvic mesh class action, group members may learn
The rejection of a $27 million settlement offer in a class action over American Medical Systems' pelvic mesh products may be included in a proposed opt out notice, with a judge mulling whether to inform group members about a little used law which allows one lead applicant to take over from another.
J&J slammed for ‘wreckage’ of a case in pelvic mesh class action appeal
A group of women harmed by pelvic mesh devices produced by Johnson & Johnson have accused it of persisting with a "wreckage" of a case in which one of its own doctors admitted the pharmaceutical company knew of the risks posed by the implants at they time they were sold worldwide.
Judge was wrong to ignore pelvic mesh doctors, J&J says in high-stakes appeal
The judge who found J&J's pelvic mesh implants defective in a high stakes class action ruling mde a "pervasive error" in disregarding the knowledge and views of the applicants' doctors, an appeals court has heard. 
The top litigation law firms of 2020
Lawyerly's Litigation Firms of 2020 delivered significant victories for clients last year in bet-the-company matters, thriving in a tumultuous year that saw courts and litigants adapt to virtual trials and other new norms that are sure to outlast the COVID-19 pandemic.
Law firms circle insurers over COVID-19 business interruption claims
At least five law firms are investigating lawsuits, including class action proceedings, in the wake of a landmark test case on COVID-19 exclusions for business interruption cover.
J&J ordered to pay $40M in pelvic mesh class action costs as stay bid tossed by court
A unit of Johnson & Johnson has been ordered to pay around $40 million in legal costs to the lead applicants in a class action over pelvic mesh implants after a judge dismissed the company's bid to stay the costs until after a high profile appeal is heard next year.
High Court asked to hear $10B COVID-19 business interruption case
The Insurance Council of Australia has asked the High Court to weigh in on its case against COVID-19 related claims in business interruption policies, following its high stakes loss in a ruling last month that found an infectious disease exclusion did not apply.